Literature DB >> 26440804

Synchronous Ipsilateral Parotid Tumors with Cytologic-Histologic Correlation.

Kristina Gvozdjan1, John V Groth1, Tushar N Patel1, Grace Guzman1, Odile David1, Robert J Cabay2.   

Abstract

Synchronous ipsilateral tumor formation within a major salivary gland is a very rare event. In this case, a 54-year-old female tobacco smoker presented with a slowly enlarging left parotid gland. Computed tomography of the neck demonstrated a solid mass superficial to a cystic mass in the deep lobe of the gland. Ultrasound-guided fine needle aspiration yielded oncocytic cells, lymphoid cells, and granular debris along with rare cohesive groups of basaloid cells. Parotidectomy was performed, and the resected gland was found to contain two adjacent but distinct masses. One mass, a predominantly solid, well-circumscribed lesion composed of ribbons of double-layered oncocytic cells and a lymphoid stroma with germinal center formation, was a Warthin tumor. The other mass, a predominantly cystic lesion composed of cords and nests of basaloid cells with associated deposits of basement membrane-like material, was a basal cell adenoma of the membranous type. To our knowledge, this is the first reported case of synchronous Warthin tumor and basal cell adenoma of the parotid gland with cytologic-histologic correlation attributable to each tumor.

Entities:  

Keywords:  Basal cell adenoma; Cytopathology; Head and neck pathology; Parotid gland; Salivary gland; Warthin tumor

Mesh:

Year:  2015        PMID: 26440804      PMCID: PMC4838957          DOI: 10.1007/s12105-015-0658-5

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  14 in total

Review 1.  Salivary gland neoplasia: a review for the practicing pathologist.

Authors:  Richard J Zarbo
Journal:  Mod Pathol       Date:  2002-03       Impact factor: 7.842

Review 2.  Synchronous tumours of the parotid gland with different histology.

Authors:  P M Goh; E Cheah
Journal:  Br J Oral Maxillofac Surg       Date:  1989-06       Impact factor: 1.651

3.  Using time-dependent covariate analysis to elucidate the relation of smoking history to Warthin's tumor risk.

Authors:  Laurence S Freedman; Bernice Oberman; Siegal Sadetzki
Journal:  Am J Epidemiol       Date:  2009-09-15       Impact factor: 4.897

4.  Basal cell adenoma: a diagnostic dilemma on fine needle aspiration cytology.

Authors:  Nalini Gupta; Amanjit Bal; Ashok Kumar Gupta; Arvind Rajwanshi
Journal:  Diagn Cytopathol       Date:  2011-03-04       Impact factor: 1.582

Review 5.  Review of fine-needle aspiration cytology of salivary gland neoplasms, with emphasis on differential diagnosis.

Authors:  Perkins Mukunyadzi
Journal:  Am J Clin Pathol       Date:  2002-12       Impact factor: 2.493

6.  Synchronous ipsilateral sebaceous lymphadenoma and membranous basal cell adenoma of the parotid.

Authors:  Erica L Scheller; Cedric V Pritchett; Abhishek Shukla; Jon Paul Pepper; Lawrence J Marentette; Jonathan B McHugh
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-01-09

7.  Smoking and risk of parotid gland tumors: a nationwide case-control study.

Authors:  Siegal Sadetzki; Bernice Oberman; Lori Mandelzweig; Angela Chetrit; Tehila Ben-Tal; Avital Jarus-Hakak; Shay Duvdevani; Elisabeth Cardis; Michael Wolf
Journal:  Cancer       Date:  2008-05-01       Impact factor: 6.860

Review 8.  Warthin's tumor: a 40-year experience at The Johns Hopkins Hospital.

Authors:  G H Yoo; D W Eisele; F B Askin; J S Driben; M E Johns
Journal:  Laryngoscope       Date:  1994-07       Impact factor: 3.325

9.  Basal cell adenoma of the parotid gland: Cytological diagnosis of an uncommon tumor.

Authors:  Amoolya Bhat; Madhuri Rao; V Geethamani; Archana C Shetty
Journal:  J Oral Maxillofac Pathol       Date:  2015 Jan-Apr

10.  Two-phase helical computed tomography study of salivary gland warthin tumors: a radiologic findings and surgical applications.

Authors:  Yeon Hee Joo; Jin Pyeong Kim; Jung Je Park; Seung Hoon Woo
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-08-01       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.